Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,669,866
-$11,460,970 QoQ
Shares Held
14,450
-76.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,846
of 4,664 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $60,679,237 across 7 Drug Manufacturers - General names. JNJ ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,924 | $37,091,175 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
88,471 | $11,177,425 | |
| 3 | NVO |
Novo Nordisk A S
|
123,187 | $5,905,584 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
14,450 | $3,669,866 | |
| 5 | ABBV |
AbbVie Inc.
|
9,600 | $2,415,743 | |
| 6 | PFE |
Pfizer Inc
|
9,470 | $228,037 | |
| 7 | AMRN |
Amarin Corp Plc\Uk
|
12,008 | $191,407 |
All Filings in JNJ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,669,866 | 14,450 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,130,836 | 61,900 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,889,589 | 28,459 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,687,823 | 52,248 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,871,186 | 12,250 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,810,987 | 16,950 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,586,912 | 31,717 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $244,547 | 1,509 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,770,010 | 53,161 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $4,132,080 | 26,121 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,355,804 | 34,170 | Shares | Sole | 2024-10-21 | |
| 2023-09-30 | $378,316 | 2,429 | Shares | Sole | 2024-10-21 | |
| 2023-06-30 | $1,427,113 | 8,622 | Shares | Sole | 2024-10-21 | |
| 2023-03-31 | $989,985 | 6,387 | Shares | Sole | 2024-10-21 | |
| 2022-12-31 | $1,533,497 | 8,681 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $1,137,661 | 6,409 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $667,270 | 3,765 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $760,577 | 4,446 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $1,843,275 | 11,189 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,190,526 | 19,413 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $599,932 | 3,812 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||